Zhitong Finance App News, Shisi Pharmaceutical Group (02005.HK) issued an announcement. The group has obtained drug production registration approval from the China National Drug Administration for the following three products, all of which fall under Class 4 chemicals and are deemed to have passed the consistency evaluation.

Disclaimer:Webull uses external vendor Google Translation Service for news translations where we endeavour to ensure these are correct, however, we recommend that you please double-check this information accordingly. Webull is not responsible for translation errors or issues.